Disconnector Switch
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Diphtheria, Pertussis, and Tetanus Vaccine Market Research Report 2023
1 Diphtheria, Pertussis, and Tetanus Vaccine Market Overview
1.1 Product Overview and Scope of Diphtheria, Pertussis, and Tetanus Vaccine
1.2 Diphtheria, Pertussis, and Tetanus Vaccine Segment by Type
1.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Growth Rate Analysis by Type 2022 VS 2028
1.2.2 DTaP
1.2.3 Td
1.2.4 Tdap
1.3 Diphtheria, Pertussis, and Tetanus Vaccine Segment by Application
1.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption Comparison by Application: 2022 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Vaccination Centers
1.4 Global Market Growth Prospects
1.4.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Estimates and Forecasts (2017-2028)
1.4.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity Estimates and Forecasts (2017-2028)
1.4.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Estimates and Forecasts (2017-2028)
1.5 Global Market Size by Region
1.5.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Estimates and Forecasts by Region: 2017 VS 2021 VS 2028
1.5.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Estimates and Forecasts (2017-2028)
1.5.3 Europe Diphtheria, Pertussis, and Tetanus Vaccine Estimates and Forecasts (2017-2028)
1.5.4 China Diphtheria, Pertussis, and Tetanus Vaccine Estimates and Forecasts (2017-2028)
1.5.5 Japan Diphtheria, Pertussis, and Tetanus Vaccine Estimates and Forecasts (2017-2028)
2 Market Competition by Manufacturers
2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity Market Share by Manufacturers (2017-2022)
2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Manufacturers (2017-2022)
2.3 Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Diphtheria, Pertussis, and Tetanus Vaccine Average Price by Manufacturers (2017-2022)
2.5 Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Production Sites, Area Served, Product Types
2.6 Diphtheria, Pertussis, and Tetanus Vaccine Market Competitive Situation and Trends
2.6.1 Diphtheria, Pertussis, and Tetanus Vaccine Market Concentration Rate
2.6.2 Global 5 and 10 Largest Diphtheria, Pertussis, and Tetanus Vaccine Players Market Share by Revenue
2.6.3 Mergers & Acquisitions, Expansion
3 Production Capacity by Region
3.1 Global Production Capacity of Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Region (2017-2022)
3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Region (2017-2022)
3.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.4 North America Diphtheria, Pertussis, and Tetanus Vaccine Production
3.4.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Production Growth Rate (2017-2022)
3.4.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.5 Europe Diphtheria, Pertussis, and Tetanus Vaccine Production
3.5.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Production Growth Rate (2017-2022)
3.5.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.6 China Diphtheria, Pertussis, and Tetanus Vaccine Production
3.6.1 China Diphtheria, Pertussis, and Tetanus Vaccine Production Growth Rate (2017-2022)
3.6.2 China Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.7 Japan Diphtheria, Pertussis, and Tetanus Vaccine Production
3.7.1 Japan Diphtheria, Pertussis, and Tetanus Vaccine Production Growth Rate (2017-2022)
3.7.2 Japan Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
4 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Region
4.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Region
4.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Region
4.1.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption Market Share by Region
4.2 North America
4.2.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Country
4.2.2 U.S.
4.2.3 Canada
4.3 Europe
4.3.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Country
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 China Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Country
4.5.2 Mexico
4.5.3 Brazil
5 Segment by Type
5.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Type (2017-2022)
5.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Type (2017-2022)
5.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Type (2017-2022)
6 Segment by Application
6.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Application (2017-2022)
6.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Application (2017-2022)
6.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Application (2017-2022)
7 Key Companies Profiled
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information
7.1.2 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Product Portfolio
7.1.3 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.1.4 Johnson & Johnson Main Business and Markets Served
7.1.5 Johnson & Johnson Recent Developments/Updates
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information
7.2.2 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Product Portfolio
7.2.3 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.2.4 GlaxoSmithKline Main Business and Markets Served
7.2.5 GlaxoSmithKline Recent Developments/Updates
7.3 Sanofi
7.3.1 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information
7.3.2 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Product Portfolio
7.3.3 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.3.4 Sanofi Main Business and Markets Served
7.3.5 Sanofi Recent Developments/Updates
7.4 Lanzhou Institute of Biological
7.4.1 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information
7.4.2 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Product Portfolio
7.4.3 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.4.4 Lanzhou Institute of Biological Main Business and Markets Served
7.4.5 Lanzhou Institute of Biological Recent Developments/Updates
7.5 Merck
7.5.1 Merck Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information
7.5.2 Merck Diphtheria, Pertussis, and Tetanus Vaccine Product Portfolio
7.5.3 Merck Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.5.4 Merck Main Business and Markets Served
7.5.5 Merck Recent Developments/Updates
7.6 Novartis
7.6.1 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information
7.6.2 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Product Portfolio
7.6.3 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.6.4 Novartis Main Business and Markets Served
7.6.5 Novartis Recent Developments/Updates
7.7 AstraZeneca
7.7.1 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information
7.7.2 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Product Portfolio
7.7.3 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.7.4 AstraZeneca Main Business and Markets Served
7.7.5 AstraZeneca Recent Developments/Updates
7.8 Emergent
7.8.1 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information
7.8.2 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Product Portfolio
7.8.3 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.8.4 Emergent Main Business and Markets Served
7.7.5 Emergent Recent Developments/Updates
7.9 Astellas
7.9.1 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information
7.9.2 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Product Portfolio
7.9.3 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.9.4 Astellas Main Business and Markets Served
7.9.5 Astellas Recent Developments/Updates
8 Diphtheria, Pertussis, and Tetanus Vaccine Manufacturing Cost Analysis
8.1 Diphtheria, Pertussis, and Tetanus Vaccine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Diphtheria, Pertussis, and Tetanus Vaccine
8.4 Diphtheria, Pertussis, and Tetanus Vaccine Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Diphtheria, Pertussis, and Tetanus Vaccine Distributors List
9.3 Diphtheria, Pertussis, and Tetanus Vaccine Customers
10 Market Dynamics
10.1 Diphtheria, Pertussis, and Tetanus Vaccine Industry Trends
10.2 Diphtheria, Pertussis, and Tetanus Vaccine Market Drivers
10.3 Diphtheria, Pertussis, and Tetanus Vaccine Market Challenges
10.4 Diphtheria, Pertussis, and Tetanus Vaccine Market Restraints
11 Production and Supply Forecast
11.1 Global Forecasted Production of Diphtheria, Pertussis, and Tetanus Vaccine by Region (2023-2028)
11.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Production, Revenue Forecast (2023-2028)
11.3 Europe Diphtheria, Pertussis, and Tetanus Vaccine Production, Revenue Forecast (2023-2028)
11.4 China Diphtheria, Pertussis, and Tetanus Vaccine Production, Revenue Forecast (2023-2028)
11.5 Japan Diphtheria, Pertussis, and Tetanus Vaccine Production, Revenue Forecast (2023-2028)
12 Consumption and Demand Forecast
12.1 Global Forecasted Demand Analysis of Diphtheria, Pertussis, and Tetanus Vaccine
12.2 North America Forecasted Consumption of Diphtheria, Pertussis, and Tetanus Vaccine by Country
12.3 Europe Market Forecasted Consumption of Diphtheria, Pertussis, and Tetanus Vaccine by Country
12.4 Asia Pacific Market Forecasted Consumption of Diphtheria, Pertussis, and Tetanus Vaccine by Region
12.5 Latin America Forecasted Consumption of Diphtheria, Pertussis, and Tetanus Vaccine by Country
13 Forecast by Type and by Application (2023-2028)
13.1 Global Production, Revenue and Price Forecast by Type (2023-2028)
13.1.1 Global Forecasted Production of Diphtheria, Pertussis, and Tetanus Vaccine by Type (2023-2028)
13.1.2 Global Forecasted Revenue of Diphtheria, Pertussis, and Tetanus Vaccine by Type (2023-2028)
13.1.3 Global Forecasted Price of Diphtheria, Pertussis, and Tetanus Vaccine by Type (2023-2028)
13.2 Global Forecasted Consumption of Diphtheria, Pertussis, and Tetanus Vaccine by Application (2023-2028)
13.2.1 Global Forecasted Production of Diphtheria, Pertussis, and Tetanus Vaccine by Application (2023-2028)
13.2.2 Global Forecasted Revenue of Diphtheria, Pertussis, and Tetanus Vaccine by Application (2023-2028)
13.2.3 Global Forecasted Price of Diphtheria, Pertussis, and Tetanus Vaccine by Application (2023-2028)
14 Research Finding and Conclusion
15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer
List of Tables
Table 1. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Type (K Units) & (US$ Million) (2022 VS 2028)
Table 2. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Application (K Units) & (US$ Million) (2022 VS 2028)
Table 3. Diphtheria, Pertussis, and Tetanus Vaccine Market Size Comparison by Region: 2017 VS 2021 VS 2028
Table 4. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity by Manufacturers (2017-2022) & (K Units)
Table 5. Global Diphtheria, Pertussis, and Tetanus Vaccine Production (K Units) by Manufacturers (2017-2022)
Table 6. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Manufacturers (2017-2022)
Table 7. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 8. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diphtheria, Pertussis, and Tetanus Vaccine as of 2021)
Table 10. Global Market Diphtheria, Pertussis, and Tetanus Vaccine Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Production Sites and Area Served
Table 12. Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Product Types
Table 13. Global Diphtheria, Pertussis, and Tetanus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (K Units) by Region (2017-2022)
Table 16. Global Diphtheria, Pertussis, and Tetanus Vaccine Production (K Units) by Region (2017-2022)
Table 17. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue (US$ Million) by Region (2017-2022)
Table 18. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Region (2017-2022)
Table 19. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 20. North America Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 21. Europe Diphtheria, Pertussis, and Tetanus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 22. China Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 23. Japan Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 24. Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption Market by Region (2017-2022) & (K Units)
Table 25. Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption Market Share by Region (2017-2022)
Table 26. North America Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Country (2017-2022) & (K Units)
Table 27. Europe Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Country (2017-2022) & (K Units)
Table 28. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Region (2017-2022) & (K Units)
Table 29. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Country (2017-2022) & (K Units)
Table 30. Global Diphtheria, Pertussis, and Tetanus Vaccine Production (K Units) by Type (2017-2022)
Table 31. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Type (2017-2022)
Table 32. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue (US$ Million) by Type (2017-2022)
Table 33. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Type (2017-2022)
Table 34. Global Diphtheria, Pertussis, and Tetanus Vaccine Price (USD/Unit) by Type (2017-2022)
Table 35. Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Application (2017-2022) & (K Units)
Table 36. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Application (2017-2022)
Table 37. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue (US$ Million) by Application (2017-2022)
Table 38. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Application (2017-2022)
Table 39. Global Diphtheria, Pertussis, and Tetanus Vaccine Price (USD/Unit) by Application (2017-2022)
Table 40. Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information
Table 41. Johnson & Johnson Specification and Application
Table 42. Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 43. Johnson & Johnson Main Business and Markets Served
Table 44. Johnson & Johnson Recent Developments/Updates
Table 45. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information
Table 46. GlaxoSmithKline Specification and Application
Table 47. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 48. GlaxoSmithKline Main Business and Markets Served
Table 49. GlaxoSmithKline Recent Developments/Updates
Table 50. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information
Table 51. Sanofi Specification and Application
Table 52. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 53. Sanofi Main Business and Markets Served
Table 54. Sanofi Recent Developments/Updates
Table 55. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information
Table 56. Lanzhou Institute of Biological Specification and Application
Table 57. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 58. Lanzhou Institute of Biological Main Business and Markets Served
Table 59. Lanzhou Institute of Biological Recent Developments/Updates
Table 60. Merck Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information
Table 61. Merck Specification and Application
Table 62. Merck Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 63. Merck Main Business and Markets Served
Table 64. Merck Recent Developments/Updates
Table 65. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information
Table 66. Novartis Specification and Application
Table 67. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 68. Novartis Main Business and Markets Served
Table 69. Novartis Recent Developments/Updates
Table 70. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information
Table 71. AstraZeneca Specification and Application
Table 72. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 73. AstraZeneca Main Business and Markets Served
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information
Table 76. Emergent Specification and Application
Table 77. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 78. Emergent Main Business and Markets Served
Table 79. Emergent Recent Developments/Updates
Table 80. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Corporation Information
Table 81. Astellas Specification and Application
Table 82. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 83. Astellas Main Business and Markets Served
Table 84. Astellas Recent Developments/Updates
Table 85. Production Base and Market Concentration Rate of Raw Material
Table 86. Key Suppliers of Raw Materials
Table 87. Diphtheria, Pertussis, and Tetanus Vaccine Distributors List
Table 88. Diphtheria, Pertussis, and Tetanus Vaccine Customers List
Table 89. Diphtheria, Pertussis, and Tetanus Vaccine Market Trends
Table 90. Diphtheria, Pertussis, and Tetanus Vaccine Market Drivers
Table 91. Diphtheria, Pertussis, and Tetanus Vaccine Market Challenges
Table 92. Diphtheria, Pertussis, and Tetanus Vaccine Market Restraints
Table 93. Global Diphtheria, Pertussis, and Tetanus Vaccine Production (K Units) Forecast by Region (2023-2028)
Table 94. North America Diphtheria, Pertussis, and Tetanus Vaccine Consumption Forecast by Country (2023-2028) & (K Units)
Table 95. Europe Diphtheria, Pertussis, and Tetanus Vaccine Consumption Forecast by Country (2023-2028) & (K Units)
Table 96. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Consumption Forecast by Region (2023-2028) & (K Units)
Table 97. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Consumption Forecast by Country (2023-2028) & (K Units)
Table 98. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Forecast by Type (2023-2028) & (K Units)
Table 99. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 100. Global Diphtheria, Pertussis, and Tetanus Vaccine Price Forecast by Type (2023-2028) & (USD/Unit)
Table 101. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Forecast by Application (2023-2028) & (K Units)
Table 102. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 103. Global Diphtheria, Pertussis, and Tetanus Vaccine Price Forecast by Application (2023-2028) & (USD/Unit)
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Diphtheria, Pertussis, and Tetanus Vaccine
Figure 2. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Type: 2022 VS 2028
Figure 3. DTaP Product Picture
Figure 4. Td Product Picture
Figure 5. Tdap Product Picture
Figure 6. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Application: 2022 VS 2028
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Vaccination Centers
Figure 10. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue (US$ Million) (2017-2028)
Figure 12. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (K Units) & (2017-2028)
Figure 13. Global Diphtheria, Pertussis, and Tetanus Vaccine Production (K Units) & (2017-2028)
Figure 14. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue (US$ Million) and Growth Rate (2017-2028)
Figure 15. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue (US$ Million) and Growth Rate (2017-2028)
Figure 16. China Diphtheria, Pertussis, and Tetanus Vaccine Revenue (US$ Million) and Growth Rate (2017-2028)
Figure 17. Japan Diphtheria, Pertussis, and Tetanus Vaccine Revenue (US$ Million) and Growth Rate (2017-2028)
Figure 18. Diphtheria, Pertussis, and Tetanus Vaccine Production Share by Manufacturers in 2021
Figure 19. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Manufacturers in 2021
Figure 20. Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 21. Global Market Diphtheria, Pertussis, and Tetanus Vaccine Average Price (USD/Unit) of Key Manufacturers in 2021
Figure 22. The Global 5 and 10 Largest Players: Market Share by Diphtheria, Pertussis, and Tetanus Vaccine Revenue in 2021
Figure 23. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Region (2017-2022)
Figure 24. North America Diphtheria, Pertussis, and Tetanus Vaccine Production (K Units) Growth Rate (2017-2022)
Figure 25. Europe Diphtheria, Pertussis, and Tetanus Vaccine Production (K Units) Growth Rate (2017-2022)
Figure 26. China Diphtheria, Pertussis, and Tetanus Vaccine Production (K Units) Growth Rate (2017-2022)
Figure 27. Japan Diphtheria, Pertussis, and Tetanus Vaccine Production (K Units) Growth Rate (2017-2022)
Figure 28. Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption Market Share by Region (2017-2022)
Figure 29. North America Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2017-2022) & (K Units)
Figure 30. North America Diphtheria, Pertussis, and Tetanus Vaccine Consumption Market Share by Country in 2021
Figure 31. Canada Diphtheria, Pertussis, and Tetanus Vaccine Consumption Growth Rate (2017-2022) & (K Units)
Figure 32. U.S. Diphtheria, Pertussis, and Tetanus Vaccine Consumption Growth Rate (2017-2022) & (K Units)
Figure 33. Europe Diphtheria, Pertussis, and Tetanus Vaccine Consumption Growth Rate (2017-2022) & (K Units)
Figure 34. Europe Diphtheria, Pertussis, and Tetanus Vaccine Consumption Market Share by Country in 2021
Figure 35. Germany Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2017-2022) & (K Units)
Figure 36. France Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2017-2022) & (K Units)
Figure 37. U.K. Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2017-2022) & (K Units)
Figure 38. Italy Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2017-2022) & (K Units)
Figure 39. Russia Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2017-2022) & (K Units)
Figure 40. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2017-2022) & (K Units)
Figure 41. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Consumption Market Share by Regions in 2021
Figure 42. China Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2017-2022) & (K Units)
Figure 43. Japan Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2017-2022) & (K Units)
Figure 44. South Korea Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2017-2022) & (K Units)
Figure 45. China Taiwan Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2017-2022) & (K Units)
Figure 46. Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2017-2022) & (K Units)
Figure 47. India Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2017-2022) & (K Units)
Figure 48. Australia Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2017-2022) & (K Units)
Figure 49. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2017-2022) & (K Units)
Figure 50. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Consumption Market Share by Country in 2021
Figure 51. Mexico Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2017-2022) & (K Units)
Figure 52. Brazil Diphtheria, Pertussis, and Tetanus Vaccine Consumption and Growth Rate (2017-2022) & (K Units)
Figure 53. Production Market Share of Diphtheria, Pertussis, and Tetanus Vaccine by Type (2017-2022)
Figure 54. Production Market Share of Diphtheria, Pertussis, and Tetanus Vaccine by Type in 2021
Figure 55. Revenue Share of Diphtheria, Pertussis, and Tetanus Vaccine by Type (2017-2022)
Figure 56. Revenue Market Share of Diphtheria, Pertussis, and Tetanus Vaccine by Type in 2021
Figure 57. Production Market Share of Diphtheria, Pertussis, and Tetanus Vaccine by Application (2017-2022)
Figure 58. Production Market Share of Diphtheria, Pertussis, and Tetanus Vaccine by Application in 2021
Figure 59. Revenue Share of Diphtheria, Pertussis, and Tetanus Vaccine by Application (2017-2022)
Figure 60. Revenue Market Share of Diphtheria, Pertussis, and Tetanus Vaccine by Application in 2021
Figure 61. Manufacturing Cost Structure of Diphtheria, Pertussis, and Tetanus Vaccine
Figure 62. Manufacturing Process Analysis of Diphtheria, Pertussis, and Tetanus Vaccine
Figure 63. Diphtheria, Pertussis, and Tetanus Vaccine Industrial Chain Analysis
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share Forecast by Region (2023-2028)
Figure 67. North America Diphtheria, Pertussis, and Tetanus Vaccine Production (K Units) Growth Rate Forecast (2023-2028)
Figure 68. Europe Diphtheria, Pertussis, and Tetanus Vaccine Production (K Units) Growth Rate Forecast (2023-2028)
Figure 69. China Diphtheria, Pertussis, and Tetanus Vaccine Production (K Units) Growth Rate Forecast (2023-2028)
Figure 70. Japan Diphtheria, Pertussis, and Tetanus Vaccine Production (K Units) Growth Rate Forecast (2023-2028)
Figure 71. Global Forecasted Demand Analysis of Diphtheria, Pertussis, and Tetanus Vaccine (2017-2028) & (K Units)
Figure 72. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share Forecast by Type (2023-2028)
Figure 73. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share Forecast by Type (2023-2028)
Figure 74. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share Forecast by Application (2023-2028)
Figure 75. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share Forecast by Application (2023-2028)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Johnson & Johnson GlaxoSmithKline Sanofi Lanzhou Institute of Biological Merck Novartis AstraZeneca Emergent Astellas